Human herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 1, 2014, Pages 451-456

  Sharon, Eyal ^a   Volchek, Ludmila ^a   Frenkel, Niza ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN E; DIHYDROFOLATE REDUCTASE; GREEN FLUORESCENT PROTEIN; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F1;

AMPLICON; ARTICLE; BINDING SITE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA SYNTHESIS; DNA VIRUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; T LYMPHOCYTE; U27 GENE; U79 GENE; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION;

BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CYCLIN A; CYCLIN E; DNA PRIMERS; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; GENES, VIRAL; GENOME, VIRAL; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HERPESVIRUS 6, HUMAN; HUMANS; PLASMIDS; RETINOBLASTOMA PROTEIN; RNA, SMALL INTERFERING; TETRAHYDROFOLATE DEHYDROGENASE; TIME FACTORS;

EID: 84891950674     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308854110     Document Type: Article

References (35)

1. Yamanishi K, Mori Y, Pellett PE (2007) Human herpesviruses 6 and 7. Fields Virology, eds Knipe DM, Howley PM (Lippincott-Raven, Philadelphia), 5th Ed, Vol 2, pp 2819-2845.
2. Gravel A, Hall CB, Flamand L (2013) Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus. J Infect Dis 207(10): 1585-1589.
3. Yamanishi K, et al. (1988) Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1(8594): 1065-1067.
4. Michael BD, Solomon T (2012) Seizures and encephalitis: Clinical features, management, and potential pathophysiologic mechanisms. Epilepsia 53(Suppl 4): 63-71.
5. Zerr DM, et al. (2012) HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol Blood Marrow Transplant 18(11): 1700-1708.
6. Lautenschlager I, Razonable RR (2012) Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: Review. Transpl Int 25(5): 493-502.
7. Virtanen JO, Jacobson S (2012) Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets 11(5): 528-544.
8. Caselli E, et al. (2012) Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLoS Pathog 8(10):e1002951.
9. Polager S, Ginsberg D (2009) p53 and E2f: Partners in life and death. Nat Rev Cancer 9(10): 738-748.
10. Wong JV, Dong P, Nevins JR, Mathey-Prevot B, You L (2011) Network calisthenics: Control of E2F dynamics in cell cycle entry. Cell Cycle 10(18): 3086-3094.
11. Mundle SD, Saberwal G (2003) Evolving intricacies and implications of E2F1 regulation. FASEB J 17(6): 569-574.
12. Singh S, Johnson J, Chellappan S (2010) Small molecule regulators of Rb-E2F pathway as modulators of transcription. Biochim Biophys Acta 1799(10-12): 788-794.
13. Helt AM, Galloway DA (2003) Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24(2): 159-169.
14. Felsani A, Mileo AM, Paggi MG (2006) Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25(38): 5277-5285.
15. Hume AJ, Kalejta RF (2009) Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div 4:1.
16. Kalejta RF, Shenk T (2003) Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci USA 100(6): 3263-3268.
17. Hume AJ, et al. (2008) Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320(5877): 797-799.
18. Mlechkovich G, Frenkel N (2007) Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells. J Virol 81(24): 13499-13508.
19. Burke JR, Deshong AJ, Pelton JG, Rubin SM (2010) Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem 285(21): 16286-16293.
20. Chang CK, Balachandran N (1991) Identification, characterization, and sequence analysis of a cDNA encoding a phosphoprotein of human herpesvirus 6. J Virol 65(6): 2884-2894.
21. Chang CK, Balachandran N (1991) Identification, characterization, and sequence analysis of a cDNA encoding a phosphoprotein of human herpesvirus 6. J Virol 65(12):7085.
22. Ohdaira H, Sekiguchi M, Miyata K, Sasaki T, Yoshida K (October 20, 2011) Acute loss of DP1, but not DP2, induces p53 mRNA and augments p21Waf1/Cip1 and senescence. Cell Biochem Funct, 10.1002/cbf.1818.
23. Lin K, Ricciardi RP (1998) The 41-kDa protein of human herpesvirus 6 specifically binds to viral DNA polymerase and greatly increases DNA synthesis. Virology 250(1): 210-219.
24. Taniguchi T, Shimamoto T, Isegawa Y, Kondo K, Yamanishi K (2000) Structure of transcripts and proteins encoded by U79-80 of human herpesvirus 6 and its subcellular localization in infected cells. Virology 271(2): 307-320.
25. Borenstein R, Singer O, Moseri A, Frenkel N (2004) Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells. J Virol 78(9): 4730-4743.
26. Johnson DG, Schwarz JK, Cress WD, Nevins JR (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365(6444): 349-352.
27. De Bolle L, Hatse S, Verbeken E, De Clercq E, Naesens L (2004) Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle. FEBS Lett 560(1-3): 25-29.
28. Takaku T, Ohyashiki JH, Zhang Y, Ohyashiki K (2005) Estimating immunoregulatory gene networks in human herpesvirus type 6-infected T cells. Biochem Biophys Res Commun 336(2): 469-477.
29. Thompson JR, Agulnick AD, Ricciardi RP (1994) A novel cis element essential for stimulated transcription of the p41 promoter of human herpesvirus 6. J Virol 68(7): 4478-4485.
30. Burrel S, Aït-Arkoub Z, Agut H, Boutolleau D (2012) Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor. Antiviral Res 93(1): 199-203.
31. Ertl PF, Powell KL (1992) Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells. J Virol 66(7): 4126-4133.
32. Bieda M, Xu X, Singer MA, Green R, Farnham PJ (2006) Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res 16(5): 595-605.
33. Rayman JB, et al. (2002) E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 16(8): 933-947.
34. Neill SD, Hemstrom C, Virtanen A, Nevins JR (1990) An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F. Proc Natl Acad Sci USA 87(5): 2008-2012.
35. Workman A, Jones C (2010) Productive infection and bICP0 early promoter activity of bovine herpesvirus 1 are stimulated by E2F1. J Virol 84(13): 6308-6317.